Naphthalenes

Polycyclic aromatic hydrocarbon compounds that consist of ten carbon atoms and eight hydrogen atoms fused into two benzene rings; it is the simplest polycyclic aromatic hydrocarbon.

Search Within Results

1,846 – 1,860 of 5,926 results

1,846

Medchemexpress LLC 1-naphthoic acid | 86-55-5 | MFCD00004007 | 99.8% | 172.18 | C11H8O2 | 500g

Naphthalene-1-carboxylic acid is a biochemical reagent that can be used as a biological material or organic compound for life science related research

Pricing & Availability

1,847

FUJIFILM BIOSCIENCES INC 3-HYDROXY-2-NAPHTHAMIDE 25 G

*Orders for this supplier are non-cancellable/non-returnable once they are processed.* 3-hydroxy-2-naphthamide 25 G. 3665-51-8 MFCD00082972

Pricing & Availability

1,848

Medchemexpress LLC 1-[(3,5-dichlorophenyl)sulfonyl]-N-[(4-fluorophenyl)methyl]-4-piperidinecarboxamide | 2227549-00-8 | >98.0% | 445.34 Da | C19H19Cl2FN2O3S | 50MG

A small-molecule chemical probe that potently and selectively inhibits the sodium-coupled citrate transporter SLC13A5 (NaCT). It is reported to act as a high-affinity, selective, and functionally irreversible inhibitor in human cells and is used as a research tool to study citrate transport and liver metabolism.

Potent, selective inhibition of human SLC13A5 (IC50 = 56 nM in HEK cells; 24 nM in HepG2 cells).
High selectivity over other SLC13 family members (IC50 > 100 μM).
Chemical formula C19H19Cl2FN2O3S and molecular weight 445.34 Da.
Purity ≥98.0% (HPLC).
Low aqueous solubility (<1 μg/mL at pH 6.8); soluble in DMSO.
High plasma protein binding in human plasma (~99%).
Moderate microsomal stability and variable hepatocyte stability across species.

Pricing & Availability

1,849

eMolecules 1416437-24-5 | 3-(Tributylstannyl)-2-pyridinecarbonitrile | Synthonix - Stock | MFCD22421757 | 393.162 | C18H30N2Sn | 98.000 | CCCC[Sn](CCCC)(CCCC)c1cccnc1C#N | 5g | 525924594

3-(Tributylstannyl)-2-pyridinecarbonitrile | Synthonix - Stock | 1416437-24-5 | MFCD22421757 | 393.162 | C18H30N2Sn | 98.000 | CCCC[Sn](CCCC)(CCCC)c1cccnc1C#N | 5g | 525924594

Pricing & Availability

1,850

Medchemexpress LLC (1R,4R)-5-(2-((R)-hexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl)-6-(6-(4-methoxypyridin-3-yl)-4- | 2769715-68-4 | 99.3% | 592.69 g/mol | C32H36N10O2 | 10 MG

BI-4732 is an orally active, reversible, ATP-competitive EGFR inhibitor with blood-brain barrier penetration that selectively targets common mutant EGFR variants and has demonstrated intracranial antitumor efficacy in preclinical models.

Orally active, reversible EGFR inhibitor with blood-brain barrier penetration.
Selective inhibition of mutant EGFR variants including L858R, T790M, and C797S.
Demonstrated intracranial antitumor efficacy in xenograft models.
High purity (99.3%) suitable for preclinical research.
Solid form; soluble in DMSO at approximately 2 mg/mL with warming and sonication.
Recommended storage: 4°C protected from light; in solution, store at -80°C (6 months) or -20°C (1 month).

Pricing & Availability

1,851

eMolecules 28493-54-1 | Benzyltributylstannane | Synthonix - Stock | MFCD30741350 | 381.191 | C19H34Sn | 95.000 | CCCC[Sn](CCCC)(CCCC)Cc1ccccc1 | 250mg | 525911853

Benzyltributylstannane | Synthonix - Stock | 28493-54-1 | MFCD30741350 | 381.191 | C19H34Sn | 95.000 | CCCC[Sn](CCCC)(CCCC)Cc1ccccc1 | 250mg | 525911853

Pricing & Availability

1,852

eMolecules 18620-03-6 | 4-iso-Propylphenylmagnesium bromide, 0.5 M in THF | Synthonix - Stock | MFCD01319911 | 223.396 | C9H11BrMg | 0.000 | [Br-].CC(C)c1ccc([Mg+])cc1 | 500ml | 437237413

4-iso-Propylphenylmagnesium bromide, 0.5 M in THF | Synthonix - Stock | 18620-03-6 | MFCD01319911 | 223.396 | C9H11BrMg | 0.000 | [Br-].CC(C)c1ccc([Mg+])cc1 | 500ml | 437237413

Pricing & Availability

1,853

eMolecules 1002719-56-3 | 4-(Methylthio)-6-(tributylstannyl)pyrimidine | Synthonix - Stock | MFCD28556920 | 415.230 | C17H32N2SSn | 95.000 | CCCC[Sn](CCCC)(CCCC)c1cc(SC)ncn1 | 500mg | 525919645

4-(Methylthio)-6-(tributylstannyl)pyrimidine | Synthonix - Stock | 1002719-56-3 | MFCD28556920 | 415.230 | C17H32N2SSn | 95.000 | CCCC[Sn](CCCC)(CCCC)c1cc(SC)ncn1 | 500mg | 525919645

Pricing & Availability

1,854

eMolecules 1629082-81-0 | (Cyclobutylmethyl)zinc bromide, 0.50 M in THF | Synthonix214.410 | C5H9BrZn | 0.000 | [Br-].[Zn+]CC1CCC1 | 100ml | 532652657

(Cyclobutylmethyl)zinc bromide, 0.50 M in THF | Synthonix | 1629082-81-0214.410 | C5H9BrZn | 0.000 | [Br-].[Zn+]CC1CCC1 | 100ml | 532652657

Pricing & Availability

1,855

eMolecules 37586-57-5 | 4-Methylpent-3-enylmagnesium bromide, 0.5M in THF | Synthonix - Stock187.363 | C6H11BrMg | 97.000 | [Br-].CC(C)=CCC[Mg+] | 100ml | 448757612

4-Methylpent-3-enylmagnesium bromide, 0.5M in THF | Synthonix - Stock | 37586-57-5187.363 | C6H11BrMg | 97.000 | [Br-].CC(C)=CCC[Mg+] | 100ml | 448757612

Pricing & Availability

1,856

eMolecules ChemScene Perfluorophenyl 222-trifluoroacetate 25g 582652133 CS-W012279 14533-84-7 MFCD00134438 280.073 C8F8O2

ChemScene Perfluorophenyl 222-trifluoroacetate 25g 582652133 CS-W012279 14533-84-7 MFCD00134438 280.073 C8F8O2

Pricing & Availability

1,857

eMolecules 2378318-41-1 | 3-(Benzyloxy)propylzinc bromide, 0.5 M in THF | Synthonix294.500 | C10H13BrOZn | 0.000 | [Br-].[Zn+]CCCOCc1ccccc1 | 50ml | 771375795

3-(Benzyloxy)propylzinc bromide, 0.5 M in THF | Synthonix | 2378318-41-1294.500 | C10H13BrOZn | 0.000 | [Br-].[Zn+]CCCOCc1ccccc1 | 50ml | 771375795

Pricing & Availability

1,858

eMolecules 126979-68-8 | 1-Ethylpentylmagnesium bromide, 0.25 M in THF | Synthonix - Stock | MFCD02260223 | 203.406 | C7H15BrMg | 0.000 | [Br-].CCCCC([Mg+])CC | 50ml | 437237176

1-Ethylpentylmagnesium bromide, 0.25 M in THF | Synthonix - Stock | 126979-68-8 | MFCD02260223 | 203.406 | C7H15BrMg | 0.000 | [Br-].CCCCC([Mg+])CC | 50ml | 437237176

Pricing & Availability

1,859

eMolecules 718628-26-3 | 2,4,6-Trimethylphenylzinc iodide, 0.50 M in THF | Synthonix311.470 | C9H11IZn | 0.000 | [I-].Cc1cc(C)c([Zn+])c(C)c1 | 100ml | 532652991

2,4,6-Trimethylphenylzinc iodide, 0.50 M in THF | Synthonix | 718628-26-3311.470 | C9H11IZn | 0.000 | [I-].Cc1cc(C)c([Zn+])c(C)c1 | 100ml | 532652991

Pricing & Availability

1,860

Medchemexpress LLC N-[4-[(4-aminophenyl)thio]phenyl]-4-[[(4-methoxyphenyl)sulfonyl]amino]-butanamide | 791835-21-7 | MFCD07784498 | 98.5% | 471.59 g·mol⁻¹ | C23H25N3O4S2 | 1 ML

BI-6C9 is a small-molecule inhibitor of the BH3 interacting domain (Bid) used in research to block tBid-mediated mitochondrial outer membrane permeabilization and downstream apoptotic signaling.

10 mM solution in DMSO, ready for in vitro experiments.
Supplied as a 1 mL aliquot for convenient handling.
High purity (98.47%) suitable for biochemical assays.
Inhibits tBid activity and prevents cytochrome c release from mitochondria.
Molecular weight 471.59 g·mol⁻¹; formula C23H25N3O4S2.

Pricing & Availability

Naphthalenes

Filtered Search Results

Narrow Results

Medchemexpress LLC 1-naphthoic acid | 86-55-5 | MFCD00004007 | 99.8% | 172.18 | C11H8O2 | 500g Small and Specialty Supplier PartnerSmall and/or specialty supplier based on Federal laws and SBA requirements.Learn More

Medchemexpress LLC 1-[(3,5-dichlorophenyl)sulfonyl]-N-[(4-fluorophenyl)methyl]-4-piperidinecarboxamide | 2227549-00-8 | >98.0% | 445.34 Da | C19H19Cl2FN2O3S | 50MG Small and Specialty Supplier PartnerSmall and/or specialty supplier based on Federal laws and SBA requirements.Learn More

Medchemexpress LLC (1R,4R)-5-(2-((R)-hexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl)-6-(6-(4-methoxypyridin-3-yl)-4- | 2769715-68-4 | 99.3% | 592.69 g/mol | C32H36N10O2 | 10 MG Small and Specialty Supplier PartnerSmall and/or specialty supplier based on Federal laws and SBA requirements.Learn More

Medchemexpress LLC 1-naphthoic acid | 86-55-5 | MFCD00004007 | 99.8% | 172.18 | C11H8O2 | 500g

Medchemexpress LLC 1-[(3,5-dichlorophenyl)sulfonyl]-N-[(4-fluorophenyl)methyl]-4-piperidinecarboxamide | 2227549-00-8 | >98.0% | 445.34 Da | C19H19Cl2FN2O3S | 50MG

Medchemexpress LLC (1R,4R)-5-(2-((R)-hexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl)-6-(6-(4-methoxypyridin-3-yl)-4- | 2769715-68-4 | 99.3% | 592.69 g/mol | C32H36N10O2 | 10 MG